# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Becton Dickinson CFO Chris DelOrefice will step down Dec. 5 as BD reports strong fiscal 2025 sales and appoints Vitor Roque int...
RBC Capital analyst Shagun Singh reiterates Becton Dickinson (NYSE:BDX) with a Sector Perform and maintains $211 price target.
Becton Dickinson (NYSE:BDX) sees Q4 sales of $5.900 billion vs $5.912 billion analyst estimate.
Becton Dickinson (NYSE:BDX) narrows FY2025 sales outlook from $21.800 billion-$21.900 billion to $21.800 billion vs $21.863 bil...
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the enrollment of t...
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, and Opentrons Labworks, Inc., recog...